ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

VTRS Viatris Inc

11.57
-0.21 (-1.78%)
01 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Viatris Inc VTRS 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
-0.21 -1.78% 11.57 08:00:00
개장가 저가 고가 종가 전일 종가
11.74 11.57 11.75 11.57 11.78
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
17/04/202405:30PRNUSViatris to Report First Quarter 2024 Financial Results on..
15/04/202421:00PRNUSViatris Appoints Corinne Le Goff as Chief Commercial Officer
15/04/202419:59PRNCAViatris Announces Launch of First Bioequivalent Generic..
01/04/202419:59PRNUSViatris Announces the Launch of RYZUMVl™ (Phentolamine..
27/03/202419:59PRNUSViatris Hosts R&D Event Focusing on its Collaboration with..
06/03/202410:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/03/202410:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/03/202410:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/03/202409:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/03/202409:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/03/202409:26EDGAR2Form 3 - Initial statement of beneficial ownership of..
05/03/202408:11EDGAR2Form 144 - Report of proposed sale of securities
28/02/202421:39EDGAR2Form 8-K - Current report
28/02/202420:30PRNUSViatris Reports Fourth-Quarter and Full-Year 2023 Financial..
28/02/202415:00PRNUSViatris and Idorsia Enter Into Significant Global Research..
24/02/202408:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/02/202408:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/02/202407:18EDGAR2Form 144 - Report of proposed sale of securities
05/02/202420:59PRNUSViatris to Announce Fourth Quarter and Full-Year 2023..
31/01/202406:40EDGAR2Form 8-K/A - Current report: [Amend]
19/01/202420:56PRNUSViatris recognised as a Top Employer 2024 in the UK for the..
06/01/202408:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/01/202410:28EDGAR2Form 144 - Report of proposed sale of securities
22/12/202306:05PRNUSViatris to Participate in 42nd Annual J.P. Morgan Healthcare..
16/12/202308:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202307:04EDGAR2Form 8-K/A - Current report: [Amend]
16/12/202307:00EDGAR2Form 8-K - Current report
16/12/202306:45PRNUSViatris Continues its Preparations for Phase 2 of its..
16/12/202306:14EDGAR2Form 8-K - Current report
16/12/202306:12EDGAR2Form 8-K - Current report
16/12/202306:05PRNUSViatris Shareholders Re-elect All Nominated Directors and..
15/12/202307:31EDGAR2Form 144 - Report of proposed sale of securities
25/11/202308:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/11/202306:30EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
25/11/202303:02EDGAR2Form 144 - Report of proposed sale of securities
14/11/202322:00PRNUSViatris to Participate in the Jefferies London Healthcare..
13/11/202322:00PRNUSViatris and Theravance Biopharma Announce Positive Top-Line..
08/11/202306:39EDGAR2Form 8-K - Current report
08/11/202306:02PRNUSViatris Reports Strong Financial and Operational Results for..
04/11/202305:36EDGAR2Form ARS - Annual Report to Security Holders
04/11/202305:33EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
04/11/202305:31EDGAR2Form DEF 14A - Other definitive proxy statements
30/10/202322:00PRNUSViatris to Host Webinar: The Power of Partnership to Address..
25/10/202305:32EDGAR2Form 8-K - Current report
25/10/202305:30EDGAR2Form PRE 14A - Other preliminary proxy statements
23/10/202322:00PRNUSViatris Named to Forbes' Annual List of the World's Best..
21/10/202306:18EDGAR2Form 8-K - Current report
21/10/202306:00PRNUSRajiv Malik to Retire as President of Viatris Effective..
18/10/202321:00PRNUSViatris Named to 3BL's 100 Best Corporate Citizens of 2023..
10/10/202322:29PRNUSViatris to Release Third Quarter 2023 Financial Results on..

최근 히스토리

Delayed Upgrade Clock